High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Leukemia and Lymphoma

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10428199609051615PMID 8624464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous bone marrow transplantation

  1993cited by this paper
• The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation.

  1993cited by this paper
• Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system.

  1993cited by this paper
• Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.

  1993cited by this paper
• One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

  1993cited by this paper
• Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.

  1992cited by this paper
• Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas.

  1991cited by this paper
• Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma.

  1991cited by this paper
• Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.

  1991cited by this paper
• High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.

  1991cited by this paper
• Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.

  1991cited by this paper
• Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

  1990cited by this paper
• Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.

  1990cited by this paper
• The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.

  1990cited by this paper
• Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.

  1990cited by this paper
• Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.

  1990cited by this paper
• The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.

  1990cited by this paper
• High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.

  1990cited by this paper
• The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation

  1990cited by this paper
• Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.

  1989cited by this paper
• High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

  1989cited by this paper
• Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

  1989cited by this paper
• Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

  1989cited by this paper
• Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

  1989cited by this paper
• Non-Hodgkin's lymphoma.

  1989cited by this paper
• Bone marrow transplantation in the treatment of patients with lymphoma.

  1989cited by this paper
• Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy.

  1989cited by this paper
• Regimen-related toxicity in patients undergoing bone marrow transplantation.

  1988cited by this paper
• Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.

  1988cited by this paper
• Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.

  1987cited by this paper
• Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

  1987cited by this paper
• High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

  1987cited by this paper
• Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

  1987cited by this paper
• Interstitial pneumonitis following autologous bone marrow transplantation.

  1986cited by this paper
• Pulmonary complications of bone marrow transplantation.

  1985cited by this paper
• Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow.

  1984cited by this paper
• Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia.

  1983cited by this paper
• Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.

  1983cited by this paper
• Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variables

  1982cited by this paper
• Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation.

  1982cited by this paper
• Risk factors in interstitial pneumonitis following allogenic bone marrow transplantation.

  1982cited by this paper
• Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma.

  1981cited by this paper
• Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins.

  1981cited by this paper
• Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation.

  1981cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas

  1979cited by this paper
• Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas.

  1979cited by this paper
• Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma.

  1978cited by this paper
• Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma

  1978cited by this paper
• On distribution-free tests for equality of survival distributions

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• The Impact of Involved Field Radiation Therapy for Patients Receiving High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant for the Treatment of Relapsed or Refractory Hodgkin Disease

  2006cites this paper
• Total body irradiation

  1999cites this paper